8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934


         Date of Report (date of earliest event reported): July 1, 2005


                           Commission File No. 0-11178
                                               -------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


               UTAH                                           87-0342734
  -------------------------------                         ------------------
  (State or other jurisdiction of                          (I.R.S. Employer
   incorporation or organization)                         Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                               -------------------
                     Address of principal executive offices


Registrant's telephone number:      (801) 566-1200
                                    --------------





- --------------------------------------------------------------------------------

                             ITEM 8.01 OTHER EVENTS

- --------------------------------------------------------------------------------

On July 1, 2005, Utah Medical Products, Inc. issued a press release providing an
update on the status of FDA litigation. A copy of the press release is attached
hereto as Exhibit 99.1


- --------------------------------------------------------------------------------

                                   SIGNATURES

- --------------------------------------------------------------------------------

     Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                UTAH MEDICAL PRODUCTS, INC.
                                                REGISTRANT


Date:       7/1/05                              By: /s/ Kevin L. Cornwell
      --------------------                         -----------------------
                                                   Kevin L. Cornwell
                                                   CEO


- --------------------------------------------------------------------------------

                                  EXHIBIT INDEX


Index
Number        Description
- ------        -----------

99.1          Press release issued July 1, 2005: UTMD Updates Status of FDA
              Lawsuit

EX-99.1

                                  EXHIBIT 99.1

Salt Lake City, Utah - On June 30, 2005 at the conclusion of a pretrial
conference for a lawsuit filed last year on behalf of the Food and Drug
Administration (FDA), Judge Bruce S. Jenkins scheduled the trial to begin on
August 30, 2005 in the U.S. District Court in Salt Lake City. The parties
estimated that the trial would last about six days.

CEO Kevin Cornwell states,

          "We remain disappointed with the length of time required to resolve
          this unnecessary lawsuit against UTMD and its employees, but are
          pleased that the time has arrived for the FDA allegations to be proven
          in Court, on the basis of the facts and the law.

          Our mission, confirmed by clinicians who use our products, has always
          been to manufacture and distribute medical devices of the highest
          quality. I remain confident that the Court will find that our
          procedures meet those directed by the Quality System Regulation, and
          result in continued release of high quality devices that perform as
          intended."

For the benefit of customers, the FDA has acknowledged that there is no claim in
this case that UTMD's products are not safe or effective. UTMD expects to
continue to manufacture and distribute all of its high quality products
worldwide without any regulatory restriction.

Utah Medical Products, Inc. (Nasdaq: UTMD), with particular interest in health
care for women and their babies, develops, manufactures, assembles and markets a
broad range of well-established, proven safe and effective, disposable and
reusable specialty medical devices.